JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4776
TRI-Continental Corp
TY
$1.83B
| $572K | ﹤0.01% |
18,048
+4,888
| +37% | +$162K |
2022 Q4
8 quarters
|
|
4777
PUT
ResMed
RMD
$31.6B
| $572K | ﹤0.01% |
+2,500
| New | +$602K |
2024 Q4
0 quarters
|
|
4778
Calumet Specialty Products
CLMT
$4.86B
| $565K | ﹤0.01% |
25,660
+24,660
| +2,466% | +$518K |
2024 Q3
1 quarter
|
|
4779
Invesco S&P 100 Equal Weight ETF
EQWL
$2.79B
| $562K | ﹤0.01% |
5,494
+509
| +10% | +$53.1K |
2024 Q2
2 quarters
|
|
4780
Grocery Outlet
GO
$1.15B
| $562K | ﹤0.01% |
35,977
-17,918
| -33% | -$312K |
2019 Q2
22 quarters
|
|
|
PYCR
4781
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $561K | ﹤0.01% |
30,231
-54,305
| -64% | -$906K |
2021 Q3
13 quarters
|
|
|
SILA
4782
DELISTED
Sila Realty Trust
SILA
| $560K | ﹤0.01% |
23,041
-13,468
| -37% | -$339K |
2024 Q2
2 quarters
|
|
|
KG
4783
Kestrel Group
KG
$41M
| $560K | ﹤0.01% |
16,568
+9,810
| +145% | +$314K |
2013 Q2
46 quarters
|
|
4784
iShares CMBS ETF
CMBS
$459M
| $560K | ﹤0.01% |
11,861
+881
| +8% | +$42K |
2020 Q4
16 quarters
|
|
4785
Quad
QUAD
$485M
| $559K | ﹤0.01% |
80,250
+66,111
| +468% | +$448K |
2013 Q2
46 quarters
|
|
4786
CALL
Lumen
LUMN
$5.93B
| $556K | ﹤0.01% |
104,700
| – | – |
2023 Q3
5 quarters
|
|
4787
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.71B
| $552K | ﹤0.01% |
11,273
-1,368
| -11% | -$69.9K |
2017 Q2
30 quarters
|
|
4788
Design Therapeutics
DSGN
$772M
| $550K | ﹤0.01% |
89,215
+48,528
| +119% | +$281K |
2021 Q2
14 quarters
|
|
4789
ALPS Sector Dividend Dogs ETF
SDOG
$1.36B
| $549K | ﹤0.01% |
9,709
+1,800
| +23% | +$106K |
2020 Q4
16 quarters
|
|
|
LNKB
4790
DELISTED
LINKBANCORP
LNKB
| $548K | ﹤0.01% |
73,217
+43,429
| +146% | +$309K |
2023 Q4
4 quarters
|
|
4791
Ivanhoe Electric
IE
$1.67B
| $545K | ﹤0.01% |
72,196
+5,245
| +8% | +$48.5K |
2022 Q2
10 quarters
|
|
4792
Janus Henderson Securitized Income ETF
JSI
$1.53B
| $544K | ﹤0.01% |
+10,506
| New | +$547K |
2024 Q4
0 quarters
|
|
4793
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.03B
| $544K | ﹤0.01% |
24,983
-650
| -3% | -$13.9K |
2020 Q2
18 quarters
|
|
4794
CPI Card Group
PMTS
$288M
| $544K | ﹤0.01% |
18,188
+15,923
| +703% | +$442K |
2022 Q4
8 quarters
|
|
4795
Rimini Street
RMNI
$396M
| $543K | ﹤0.01% |
203,430
+103,828
| +104% | +$212K |
2018 Q2
26 quarters
|
|
4796
T. Rowe Price Dividend Growth ETF
TDVG
$1.42B
| $542K | ﹤0.01% |
13,701
-91,555
| -87% | -$3.73M |
2022 Q4
8 quarters
|
|
4797
Xtrackers MSCI USA ESG Leaders Equity ETF
USSG
$590M
| $542K | ﹤0.01% |
10,044
+5,344
| +114% | +$292K |
2022 Q4
8 quarters
|
|
4798
PUT
Corning
GLW
$141B
| $542K | ﹤0.01% |
11,400
-3,300
| -22% | -$156K |
2021 Q3
13 quarters
|
|
|
XXCH
4799
DELISTED
Direxion Daily MSCI Emerging Markets ex China Bull 2X Shares
XXCH
| $539K | ﹤0.01% |
25,000
| – | – |
2024 Q1
3 quarters
|
|
4800
Janus Henderson B-BBB CLO ETF
JBBB
$1.52B
| $538K | ﹤0.01% |
10,938
+9,216
| +535% | +$453K |
2024 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.